These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31828200)

  • 1. A retrospective study of the role of long-acting injectable antipsychotics in preventing rehospitalization in early psychosis with cannabis use.
    Rozin E; Vanaharam V; D'Mello D; Palazzolo S; Adams C
    Addict Behav Rep; 2019 Dec; 10():100221. PubMed ID: 31828200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.
    Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
    JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiating long-acting injectable antipsychotics during acute admission for patients with schizophrenia--A 3-year follow-up.
    Liu CC; Shan JC; Chiang CL; Hsieh MH; Liu CM; Chien YL; Chen SC; Hwang TJ
    J Formos Med Assoc; 2015 Jun; 114(6):539-45. PubMed ID: 26062967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder.
    Abdel-Baki A; Thibault D; Medrano S; Stip E; Ladouceur M; Tahir R; Potvin S
    Early Interv Psychiatry; 2020 Feb; 14(1):69-79. PubMed ID: 31125513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting injectable antipsychotics in the elderly: guidelines for effective use.
    Masand PS; Gupta S
    Drugs Aging; 2003; 20(15):1099-110. PubMed ID: 14651433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of early use of long-acting injectable antipsychotics on psychotic relapses and hospitalizations in first-episode psychosis.
    Abdel-Baki A; Medrano S; Maranda C; Ladouceur M; Tahir R; Stip E; Potvin S
    Int Clin Psychopharmacol; 2020 Jul; 35(4):221-228. PubMed ID: 32282448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of adherence and persistence with oral versus long-acting injectable antipsychotics in patients with early psychosis.
    Titus-Lay EN; Ansara ED; Isaacs AN; Ott CA
    Ment Health Clin; 2018 Mar; 8(2):56-62. PubMed ID: 29955546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis.
    Foglia E; Schoeler T; Klamerus E; Morgan K; Bhattacharyya S
    Psychol Med; 2017 Jul; 47(10):1691-1705. PubMed ID: 28179039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic formulation and one-year rehospitalization of schizophrenia patients: a population-based cohort study.
    Huang SS; Lin CH; Loh el-W; Yang HY; Chan CH; Lan TH
    Psychiatr Serv; 2013 Dec; 64(12):1259-62. PubMed ID: 24292730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics.
    Lin CH; Chan HY; Wang FC; Hsu CC
    Ther Adv Psychopharmacol; 2022; 12():20451253221079165. PubMed ID: 35340566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis use correlates with aggressive behavior and long-acting injectable antipsychotic treatment in Asian patients with schizophrenia.
    Park SC; Oh HS; Tripathi A; Kallivayalil RA; Avasthi A; Grover S; Tanra AJ; Kanba S; Kato TA; Inada T; Chee KY; Chong MY; Lin SK; Sim K; Xiang YT; Tan CH; Javed A; Sartorius N; Shinfuku N; Park YC
    Nord J Psychiatry; 2019 Aug; 73(6):323-330. PubMed ID: 31240984
    [No Abstract]   [Full Text] [Related]  

  • 12. Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia.
    Kane JM; McEvoy JP; Correll CU; Llorca PM
    CNS Drugs; 2021 Nov; 35(11):1189-1205. PubMed ID: 34636025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long acting injectable antipsychotics in the treatment of schizophrenia: a review of literature].
    Graffino M; Montemagni C; Mingrone C; Rocca P
    Riv Psichiatr; 2014; 49(3):115-23. PubMed ID: 25000887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
    J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics on Time to Rehospitalization Within 1 Year of Discharge in Elderly Patients With Schizophrenia.
    Lin CH; Chen FC; Chan HY; Hsu CC
    Am J Geriatr Psychiatry; 2020 Jan; 28(1):23-30. PubMed ID: 31481273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to rehospitalization in patients with bipolar mania discharged on long-acting injectable or oral antipsychotics.
    Lin CH; Chan HY; Hsu CC; Chen FC
    J Affect Disord; 2021 Jan; 279():292-298. PubMed ID: 33096327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis use and clinical outcome in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.
    Scheffler F; Phahladira L; Luckhoff H; du Plessis S; Asmal L; Kilian S; Forti MD; Murray R; Emsley R
    Psychiatry Res; 2021 Aug; 302():114022. PubMed ID: 34052461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.
    Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A;
    Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.